Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	39.27	69.53	66.39	59.97	142.75	28.38
Short-Term Investments	141.51	188.39	270.5	306.17	342.51	161.94
Cash & Short-Term Investments	180.79	257.92	336.89	366.13	485.26	190.32
Cash Growth	-43.88%	-23.44%	-7.99%	-24.55%	154.97%	370.80%
Receivables	-	-	-	2	2	2
Prepaid Expenses	8.89	8.43	8.8	6.57	4.52	1.31
Restricted Cash	0.43	-	0.86	0.57	0.57	-
Total Current Assets	190.1	266.34	346.54	375.27	492.34	193.63
Property, Plant & Equipment	45.34	47.58	53.42	57.77	6.09	11.3
Other Long-Term Assets	2.45	2.57	2.61	3.43	1.73	2.32
Total Assets	237.89	316.49	402.57	436.47	500.16	207.25
Accounts Payable	2.61	1.6	2.79	4.45	3.23	1.84
Accrued Expenses	9.51	14.76	14.11	16.23	9.22	5.35
Current Portion of Leases	2.53	2.45	2.08	1.77	1.5	0.96
Current Income Taxes Payable	-	-	-	0.04	0.05	-
Current Unearned Revenue	23.37	17.62	25.67	31.79	26.02	31.98
Other Current Liabilities	2	1.74	1.29	1.27	0.67	0.79
Total Current Liabilities	40.03	38.17	45.94	55.55	40.69	40.92
Long-Term Leases	32.47	34.04	36.84	39.36	-	6.93
Long-Term Unearned Revenue	30.44	44.77	66.68	92.09	114.72	120.81
Other Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	102.94	116.98	149.46	186.99	155.41	168.65
Common Stock	0.11	0.11	0.1	0.09	0.09	0.04
Additional Paid-In Capital	715.04	700.63	624.08	522.61	506.76	141.64
Retained Earnings	-580.29	-501.56	-371.26	-269.51	-161.34	-103.1
Comprehensive Income & Other	0.09	0.34	0.19	-3.71	-0.77	0.02
Total Common Equity	134.95	199.52	253.11	249.48	344.75	38.6
Shareholders' Equity	134.95	199.52	253.11	249.48	344.75	38.6
Total Liabilities & Equity	237.89	316.49	402.57	436.47	500.16	207.25
Total Debt	35.01	36.49	38.92	41.13	1.5	7.88
Net Cash (Debt)	145.78	221.42	297.97	325	483.75	182.44
Net Cash Growth	-48.72%	-25.69%	-8.32%	-32.82%	165.16%	472.15%
Net Cash Per Share	1.32	2.03	3.15	3.70	7.79	5.71
Filing Date Shares Outstanding	111.26	108.11	106.72	88.2	87.71	14.2
Total Common Shares Outstanding	110.87	107.73	102.2	88.18	87.6	13.3
Working Capital	150.08	228.17	300.6	319.73	451.65	152.72
Book Value Per Share	1.22	1.85	2.48	2.83	3.94	2.90
Tangible Book Value	134.95	199.52	253.11	249.48	344.75	38.6
Tangible Book Value Per Share	1.22	1.85	2.48	2.83	3.94	2.90
Machinery	13.57	13.32	12.88	11.65	6.25	5.14
Construction In Progress	0.78	0.15	0.04	0.01	0.74	-
Leasehold Improvements	2.93	2.87	2.86	2.78	0.25	0.25

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q